ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GSD Goldshield Grp

486.25
0.00 (0.00%)
16 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Goldshield Grp LSE:GSD London Ordinary Share GB0002893823 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 486.25 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Acquisition

18/04/2001 2:05pm

UK Regulatory


RNS Number:2409C
Goldshield Group PLC
18 April 2001


For Immediate Release:                                           18  April 2001



Goldshield Group plc



                   US Acquisition from Twinlab Corporation



Goldshield Group plc ("Goldshield") announces the acquisition from Twinlab
Corporation ("Twinlab") of two operating divisions, Changes International ("
Changes") and PR Nutrition ("PR") for a cash consideration of $5 million, paid
on completion on 17 April 2001.



Twinlab is a nutritional supplement company based in Long Island, New York,
US. Of the divisions being acquired by Goldshield, Changes develops, markets
and sells a range of health products while PR is one of the leading providers
of nutritional products within the US marketplace.  As a result of this
acquisition Goldshield will gain immediate access to both divisions' extensive
lists of US, Canadian and UK distributors. The US and Canada are both markets
where Goldshield is gaining an increasing market presence through the sale and
distribution of its own and acquired products.



Changes develops, markets and sells vitamins, herbs and nutritional
supplements under the Changes brand through a network of independent
distributors. The Changes products are specially formulated and packaged for
distribution and are not intended for sale to retail outlets. Changes' product
line addresses specific needs in the areas of weight management, nutritional
defense, advanced daily nutrition, cardio-care and focused nutritional
solutions. Operating under Twinlab's charging structure and cost base,
operating losses attributable to Changes for the year to 31 December 2000 were
$1.5 million.



The second division of Twinlab to be acquired, PR, develops, markets and sells
nutritionally enhanced food bars, diet programmes and other nutritional
products under the PR Bar and PR Nutrition brand names for sales to consumers
through direct and specialty mailings and direct response sales. Operating
under Twinlab's charging structure and cost base, operating losses
attributable to PR for the year to 31 December 2000 were $232,000.



Under the terms of the acquisition Goldshield will purchase the assets,
know-how, trademarks and inventory with a value of $1.6 million in relation to
Changes and PR.



Ajit Patel, Executive Chairman of Goldshield Group plc, said



"We are confident that these acquisitions will provide us with a further
database of highly valuable distributors within the US and Canada as well as
enhancing our product range. As with our previous US acquisitions it is our
aim to utilise our drive and experience together with the infrastructure and
direct sales expertise already gained in this market to continue to increase
our foothold in one of the world's largest nutritional sales markets."



For Further Information Please Contact:


Goldshield Group plc                                 Tel:  +44 (0) 20 8649 8500
Ajit Patel, Executive Chairman
Rakesh Patel, Finance Director

Buchanan Communications                             Tel:  + 44 (0) 20 7466 5000
Nicola How / Louise Bolton


Notes to editors:

Goldshield Group plc: a profitable, British, marketing-led, emerging
pharmaceutical company based in Croydon, Surrey, was founded in 1990, to sell
healthcare and pharmaceutical products internationally.   In June 1998
Goldshield floated on the London Stock Exchange and currently has a market
capitalisation of around #250 million.

1 Year Goldshield Chart

1 Year Goldshield Chart

1 Month Goldshield Chart

1 Month Goldshield Chart

Your Recent History

Delayed Upgrade Clock